Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Mar. 31, 2023 |
Mar. 10, 2022 |
|
| Shareholders' Equity | |||
| Stock repurchase program remaining authorized repurchase amount | $ 4.0 | $ 10.0 | |
| Stock repurchase program authorized amount | $ 6.0 | ||
| Number of underwriters warrants exercised or expired | 0 | ||
| Number of shares reacquired | 686,097 | ||
| Underwriter Warrant to purchase shares | 240,100 | ||
| Warrant exercise price (in dollars per share) | $ 11.00 |
| X | ||||||||||
- Definition Number of underwriters warrants exercised or expired. No definition available.
|
| X | ||||||||||
- Definition Amount of stock repurchase plan authorized. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount remaining of a stock repurchase plan authorized. No definition available.
|
| X | ||||||||||
- Definition Number of shares that have been repurchased and retired during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|